Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
25%
ALSO IN CANC
CANC
56
HOLDINGS
11%
ALSO IN BBH
SECTOR DRIFT (BBH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 5.0% | 6.0% | 5.0% |
|
BEIGENE LTD. SPONSORED ADR | 3.1% | 3.2% | 3.1% |
|
AMGEN INC | 15.6% | 2.0% | 2.0% |
|
GILEAD SCIENCES INC | 12.5% | 1.0% | 1.0% |
|
NATERA INC | 5.1% | 0.9% | 0.9% |
BBH Overweight Relative to CANC
|
AMGEN INC | 13.5% |
|
GILEAD SCIENCES INC | 11.5% |
|
VERTEX PHARMACEUTICALS INC | 8.5% |
|
REGENERON PHARMACEUTICALS | 7.0% |
|
MODERNA, INC. | 5.5% |
|
IQVIA HOLDINGS INC | 4.9% |
 |
ARGENX SE ADR | 4.7% |
|
NATERA INC | 4.1% |
|
ILLUMINA INC | 3.3% |
|
BIOGEN IDEC INC | 3.1% |
BBH Underweight Relative to CANC
|
ELI LILLY & CO | -5.4% |
|
COGENT BIOSCIENCES INC | -4.8% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.4% |
|
NOVARTIS AG | -3.8% |
|
MERCK & CO. INC. | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
ABBVIE INC | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.1% |
|
JOHNSON & JOHNSON | -3.1% |
|
IMMUNOME, INC. | -3.0% |